2022 HCPCS Codes > M Codes >

M1003

Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic disease modifying anti-rheumatic drug therapy for ra

  • 2021 Status Change: Add procedure or modifier code
  • Effective Date: 2019-01-01
  • Medicare Coverage Status: Carrier Judgement
  • BETOS Classification: Undefined codes

Medicare has not assigned a fee schedule for this code

M1002       M1004